301087 可孚医疗
已收盘 04-30 15:00:00
资讯
新帖
简况
可孚医疗(01187):发售价厘定为每股H股39.33港元
智通财经网 · 05-04 06:38
可孚医疗(01187):发售价厘定为每股H股39.33港元
【机构调研记录】泓德基金调研可孚医疗、新洋丰等10只个股(附名单)
证券之星 · 05-01
【机构调研记录】泓德基金调研可孚医疗、新洋丰等10只个股(附名单)
可孚医疗(301087)2026年一季报简析:营收净利润同比双双增长,公司应收账款体量较大
证券之星 · 05-01
可孚医疗(301087)2026年一季报简析:营收净利润同比双双增长,公司应收账款体量较大
新股消息 | 可孚医疗(01187)孖展认购录得327.4亿港元 超购307.3倍 一手入场费3972.7港元
智通财经 · 04-30
新股消息 | 可孚医疗(01187)孖展认购录得327.4亿港元 超购307.3倍 一手入场费3972.7港元
图解可孚医疗一季报:第一季度单季净利润同比增长17.08%
证券之星 · 04-29
图解可孚医疗一季报:第一季度单季净利润同比增长17.08%
可孚医疗(301087)3月31日股东户数1.64万户,较上期减少3.61%
证券之星 · 04-29
可孚医疗(301087)3月31日股东户数1.64万户,较上期减少3.61%
可孚医疗(301087.SZ)发布一季度业绩,归母净利润1.07亿元,增长17.08%
智通财经 · 04-29
可孚医疗(301087.SZ)发布一季度业绩,归母净利润1.07亿元,增长17.08%
可孚医疗开启招股:拟募资10亿港元 5月6日上市 蓝思科技加持
雷递网 · 04-28
可孚医疗开启招股:拟募资10亿港元 5月6日上市 蓝思科技加持
可孚医疗(01187)拟全球发售2700万股H股 引入蓝思科技(香港)等基石投资者
智通财经 · 04-27
可孚医疗(01187)拟全球发售2700万股H股 引入蓝思科技(香港)等基石投资者
4月15日可孚医疗涨7.81%,华银健康生活主题灵活配置基金重仓该股
证券之星 · 04-15
4月15日可孚医疗涨7.81%,华银健康生活主题灵活配置基金重仓该股
可孚医疗涨7.81%,开源证券一个月前给出“买入”评级
证券之星 · 04-15
可孚医疗涨7.81%,开源证券一个月前给出“买入”评级
诺和诺德与OpenAI达成战略合作;再生元牵手Telix
21世纪经济报道 · 04-15
诺和诺德与OpenAI达成战略合作;再生元牵手Telix
公告精选︱佛塑科技:预计第一季度净利润同比上升1992.74%-2663.99%;可孚医疗:拟1亿元-2亿元回购股份
格隆汇 · 04-14
公告精选︱佛塑科技:预计第一季度净利润同比上升1992.74%-2663.99%;可孚医疗:拟1亿元-2亿元回购股份
可孚医疗最新公告:拟1亿-2亿元回购公司股份
中金财经 · 04-14
可孚医疗最新公告:拟1亿-2亿元回购公司股份
4月13日可孚医疗跌6.47%,国泰金鹰增长混合基金重仓该股
证券之星 · 04-13
4月13日可孚医疗跌6.47%,国泰金鹰增长混合基金重仓该股
AI医疗全场景落地,深睿医疗、飞利浦、可孚医疗亮相CMEF
微博财经-财道工作室 · 04-12
AI医疗全场景落地,深睿医疗、飞利浦、可孚医疗亮相CMEF
可孚医疗通过上市聆讯:年营收34亿利润3.7亿 张敏夫妇控制54%股权
雷递网 · 04-11
可孚医疗通过上市聆讯:年营收34亿利润3.7亿 张敏夫妇控制54%股权
夫妻店的资本局:可孚医疗冲刺港交所后得过三关
蓝鲸财经 · 04-10
夫妻店的资本局:可孚医疗冲刺港交所后得过三关
可孚医疗(301087)披露2025年年度分红派息实施公告,4月3日股价下跌0.67%
证券之星 · 04-03
可孚医疗(301087)披露2025年年度分红派息实施公告,4月3日股价下跌0.67%
可孚医疗(301087)披露2025年度网上业绩说明会安排,3月23日股价下跌4.13%
证券之星 · 03-23
可孚医疗(301087)披露2025年度网上业绩说明会安排,3月23日股价下跌4.13%
加载更多
公司概况
公司名称:
可孚医疗科技股份有限公司
所属行业:
专用设备制造业
上市日期:
2021-10-25
主营业务:
可孚医疗科技股份有限公司的主营业务是医疗器械研发、生产、销售和服务。公司的主要产品是血糖尿酸监测系列、血压计、血氧仪、体温计、胎心仪、居家检测试纸、矫正/矫姿系列、助听器、轮椅、护理床、助行器、移位机、听力计、敷贴/敷料系列、健康防护系列、感染防控系列、成人护理系列、造口护理系列、呼吸机、制氧机、雾化器、便携制氧器、鼻腔护理、理疗仪、膏贴、拔罐、针灸针、按摩器、艾叶及制成品、刮痧板。
发行价格:
93.09
{"stockData":{"symbol":"301087","market":"SZ","secType":"STK","nameCN":"可孚医疗","latestPrice":53.02,"timestamp":1777532628000,"preClose":53.35,"halted":0,"volume":3919238,"delay":0,"changeRate":-0.0062,"floatShares":194000000,"shares":209000000,"eps":1.8537,"marketStatus":"已收盘","change":-0.33,"latestTime":"04-30 15:00:00","open":53.9,"high":54.49,"low":52.18,"amount":208000000,"amplitude":0.0433,"askPrice":53.03,"askSize":14,"bidPrice":53.02,"bidSize":612,"shortable":0,"etf":0,"ttmEps":1.8537,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1778031000000},"marketStatusCode":5,"adr":0,"adjPreClose":53.35,"symbolType":"stock","openAndCloseTimeList":[[1777512600000,1777519800000],[1777525200000,1777532400000]],"highLimit":58.69,"lowLimit":48.02,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":208897000,"isCdr":false,"pbRate":2.29,"roa":"--","peRate":28.602255,"roe":"2.18%","epsLYR":1.83,"committee":0.698734,"marketValue":11076000000,"turnoverRate":0.0202,"status":1,"hkstockBrief":{"symbol":"01187","market":"HK","secType":"STK","nameCN":"可孚医疗","latestPrice":39.33,"timestamp":1777881600000,"preClose":39.33,"halted":9,"volume":0,"delay":0,"premium":"-35.31"},"floatMarketCap":10285000000},"requestUrl":"/m/hq/s/301087","defaultTab":"news","newsList":[{"id":"2632986148","title":"可孚医疗(01187):发售价厘定为每股H股39.33港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2632986148","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632986148?lang=zh_cn&edition=full","pubTime":"2026-05-04 06:38","pubTimestamp":1777847880,"startTime":"0","endTime":"0","summary":"智通财经APP讯,可孚医疗 发布公告,发售价已于2026年5月3日厘定为每股H股39.33港元。假设全球发售于2026年5月6日(星期三)上午八时正或之前成为无条件,预期H股将于2026年5月6日(星期三)上午九时正在联交所主板开始买卖。H股将以每手100股H股进行交易。H股的股份代号为1187。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1437705.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["301087","EWH","01187","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632537693","title":"【机构调研记录】泓德基金调研可孚医疗、新洋丰等10只个股(附名单)","url":"https://stock-news.laohu8.com/highlight/detail?id=2632537693","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632537693?lang=zh_cn&edition=full","pubTime":"2026-05-01 08:03","pubTimestamp":1777593793,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及4月30日披露的机构调研信息,泓德基金近期对10家上市公司进行了调研,相关名单如下:1)可孚医疗 调研纪要:公司通过自营渠道捕捉用户需求,持续推出S1无痕矫姿带、无消音棉I呼吸机等爆款产品。公司聚焦呼吸机、助听器、矫姿带、血糖监测等品类,计划打造3至5个年销售额达10亿级的大单品。2)新洋丰 调研纪要:公司一季度复合肥整体销量增速约为10%,其中常规肥增长7.5%,新型肥增长14.7%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050100008214.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301087","BK0188","BK0229","000902","BK0027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632660419","title":"可孚医疗(301087)2026年一季报简析:营收净利润同比双双增长,公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2632660419","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632660419?lang=zh_cn&edition=full","pubTime":"2026-05-01 06:44","pubTimestamp":1777589088,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期可孚医疗发布2026年一季报。截至本报告期末,公司营业总收入10.12亿元,同比上升37.22%,归母净利润1.07亿元,同比上升17.08%。本报告期可孚医疗公司应收账款体量较大,当期应收账款占最新年报归母净利润比达115.32%。本次财报公布的各项数据指标表现一般。去年的净利率为10.93%,算上全部成本后,公司产品或服务的附加值一般。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050100007081.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301087"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631500936","title":"新股消息 | 可孚医疗(01187)孖展认购录得327.4亿港元 超购307.3倍 一手入场费3972.7港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2631500936","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631500936?lang=zh_cn&edition=full","pubTime":"2026-04-30 15:12","pubTimestamp":1777533132,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,可孚医疗4月27日起至30日招股,计划发行2700万股H股,一成于香港作公开发售,招股价最高39.33港元,集资最多10.6亿港元,每手100股,一手入场费3972.7港元。可孚医疗预期将于5月5日挂牌买卖。截至4月30日中午,可孚医疗获327.4亿港元孖展认购,以公开发售集资额1.06亿港元计,超购307.3倍。招股书显示,可孚医疗是中国最大的家用医疗器械企业之一。于2024年,中国家用康复辅具类产品市场占中国家用医疗器械市场的23.5%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1437142.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0251","301087","01187","EWH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631518540","title":"图解可孚医疗一季报:第一季度单季净利润同比增长17.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631518540","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631518540?lang=zh_cn&edition=full","pubTime":"2026-04-29 18:59","pubTimestamp":1777460377,"startTime":"0","endTime":"0","summary":"证券之星消息,可孚医疗2026年一季报显示,一季度公司主营收入10.12亿元,同比上升37.22%;归母净利润1.07亿元,同比上升17.08%;扣非净利润9379.05万元,同比上升36.88%;负债率31.03%,投资收益-273.37万元,财务费用157.58万元,毛利率55.15%。财报数据概要请见下图:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900059552.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301087"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631591628","title":"可孚医疗(301087)3月31日股东户数1.64万户,较上期减少3.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631591628","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631591628?lang=zh_cn&edition=full","pubTime":"2026-04-29 18:08","pubTimestamp":1777457319,"startTime":"0","endTime":"0","summary":"证券之星消息,近日可孚医疗披露,截至2026年3月31日公司股东户数为1.64万户,较3月10日减少614.0户,减幅为3.61%。在医疗器械行业个股中,可孚医疗股东户数低于行业平均水平,截至3月31日,医疗器械行业平均股东户数为2.2万户。从股价来看,2026年3月10日至2026年3月31日,可孚医疗区间跌幅为6.35%,在此期间股东户数减少614.0户,减幅为3.61%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900057351.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301087","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631856222","title":"可孚医疗(301087.SZ)发布一季度业绩,归母净利润1.07亿元,增长17.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631856222","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631856222?lang=zh_cn&edition=full","pubTime":"2026-04-29 15:59","pubTimestamp":1777449547,"startTime":"0","endTime":"0","summary":"智通财经APP讯,可孚医疗(301087.SZ)发布2026年第一季度报告,该公司营业收入为10.12亿元,同比增长37.22%。归属于上市公司股东的净利润为1.07亿元,同比增长17.08%。归属于上市公司股东的扣除非经常性损益的净利润为9379.05万元,同比增长36.88%。基本每股收益为0.52元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1436114.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301087","01187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630422473","title":"可孚医疗开启招股:拟募资10亿港元 5月6日上市 蓝思科技加持","url":"https://stock-news.laohu8.com/highlight/detail?id=2630422473","media":"雷递网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630422473?lang=zh_cn&edition=full","pubTime":"2026-04-28 09:26","pubTimestamp":1777339573,"startTime":"0","endTime":"0","summary":"可孚医疗科技股份有限公司(简称:“可孚医疗”,股票代码:“1187”)日前开启招股,准备2026年5月6日在港交所上市。","market":"sh","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260428/6391296516773251425501057.jpeg","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260428/6391296516773251425501057.jpeg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.leinews.com/n33452/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["01187","SGXZ49509284.SGD","BK0251","06613","IPOS","301087","BK0076","SGXZ81163826.USD","BK0064","LU1979443071.USD","BK1170","BK0028","BK0201","BK0072","BK0214","BK0196","LU1934453819.USD","300433"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630331000","title":"可孚医疗(01187)拟全球发售2700万股H股 引入蓝思科技(香港)等基石投资者","url":"https://stock-news.laohu8.com/highlight/detail?id=2630331000","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630331000?lang=zh_cn&edition=full","pubTime":"2026-04-27 06:38","pubTimestamp":1777243115,"startTime":"0","endTime":"0","summary":"智通财经APP讯,可孚医疗 于2026年4月27日-4月30日招股,拟全球发售2700万股H股,香港公开发售占10%,国际发售占90%。每股发售价将不超过39.33港元,每手100股,预期H股将于2026年5月6日(星期三)开始在联交所买卖。截至2023年、2024年及2025年12月31日止年度,该公司的收入分别为人民币28.537亿元、人民币29.829亿元及人民币33.875亿元。假设发售价为每股H股39.33港元,该公司估计将获得的全球发售所得款项净额约为10.072亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1434100.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301087","BK0064","BK0072","BK0251","SGXZ81163826.USD","BK0028","LU1934453819.USD","BK0201","06613","BK0214","LU1979443071.USD","300433","BK0196","SGXZ49509284.SGD","BK1170","BK0076"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627404720","title":"4月15日可孚医疗涨7.81%,华银健康生活主题灵活配置基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2627404720","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627404720?lang=zh_cn&edition=full","pubTime":"2026-04-15 16:14","pubTimestamp":1776240862,"startTime":"0","endTime":"0","summary":"证券之星消息,4月15日可孚医疗涨7.81%,收盘报57.84元,换手率2.7%,成交量5.24万手,成交额2.99亿元。重仓可孚医疗的前十大公募基金请见下表:该股最近90天内共有4家机构给出评级,买入评级4家。根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为华银基金的华银健康生活主题灵活配置。华银健康生活主题灵活配置目前规模为0.76亿元,最新净值1.343,较上一交易日上涨1.21%,近一年上涨30.14%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041500028660.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301087","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627047974","title":"可孚医疗涨7.81%,开源证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2627047974","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627047974?lang=zh_cn&edition=full","pubTime":"2026-04-15 16:14","pubTimestamp":1776240855,"startTime":"0","endTime":"0","summary":"今日可孚医疗涨7.81%,收盘报57.84元。2026年3月12日,开源证券研究员余汝意,陈峻,石启正发布了对可孚医疗的研报《公司信息更新报告:2025年业绩高增,“深耕+出海+授权”驱动成长》,该研报对可孚医疗给出“买入”评级。在国内高端家庭健康监测市场,与飞利浦达成战略合作获品牌授权,为长期增长注入动力,并且呼吸机业务增速强劲,因此维持“买入”评级。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041500028653.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","301087"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627045478","title":"诺和诺德与OpenAI达成战略合作;再生元牵手Telix","url":"https://stock-news.laohu8.com/highlight/detail?id=2627045478","media":"21世纪经济报道","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627045478?lang=zh_cn&edition=full","pubTime":"2026-04-15 08:01","pubTimestamp":1776211308,"startTime":"0","endTime":"0","summary":"政策动向国家医疗保障局持续开展定点医药机构违法违规使用医保基金自查自纠工作国家医疗保障局近日在全国范围内组织开展2026年定点医药机构违法违规使用医保基金自查自纠工作。自查自纠聚焦重点领域“逐渐细化、持续深化”。在既往心血管内科、骨科、血液净化、康复、医学影像、临床检验、肿瘤、麻醉、重症医学等9个重点领域的基础上,本年度进一步将口腔、内分泌、精神医学3个领域纳入自查自纠范围。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604153705224747.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604153705224747.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["002437","02196","600513","NVOH","LU1093756168.USD","BK4599","NVO","LU1093756325.SGD","BK4532","NVOX","300558","301087","REGN","688177","IE00BKVL7J92.USD","603087","BK4588","600196","BK4007","IE00BZ1G4Q59.USD","LU0154236417.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627447618","title":"公告精选︱佛塑科技:预计第一季度净利润同比上升1992.74%-2663.99%;可孚医疗:拟1亿元-2亿元回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2627447618","media":"格隆汇","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627447618?lang=zh_cn&edition=full","pubTime":"2026-04-14 22:43","pubTimestamp":1776177816,"startTime":"0","endTime":"0","summary":"光峰科技:成为某新能源车企定点供应商","market":"fut","thumbnail":"https://img7.gelonghui.com/column/2/111.png?guru_height=540&guru_width=375","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/2/111.png?guru_height=540&guru_width=375"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/4411155","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["000973","301087"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627417201","title":"可孚医疗最新公告:拟1亿-2亿元回购公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2627417201","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627417201?lang=zh_cn&edition=full","pubTime":"2026-04-14 18:33","pubTimestamp":1776162785,"startTime":"0","endTime":"0","summary":"可孚医疗(301087.SZ)公告称,公司第三届董事会第四次会议审议通过了《关于回购公司股份方案的议案》。基于对公司未来发展的信心及健全长效激励机制的需要,公司拟使用自有资金以集中竞价交易方式回购部分A股股份。本次回购资金总额不低于1亿元且不超过2亿元,回购价格不超过86.60元/股。预计回购股份数量占总股本的0.55%至1.11%。回购股份将用于员工持股计划或股权激励,若未在规定期限内转让完毕则予以注销。回购实施期限为自董事会审议通过之日起12个月内。为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260414/32143113.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["301087","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627335824","title":"4月13日可孚医疗跌6.47%,国泰金鹰增长混合基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2627335824","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627335824?lang=zh_cn&edition=full","pubTime":"2026-04-13 16:17","pubTimestamp":1776068263,"startTime":"0","endTime":"0","summary":"证券之星消息,4月13日可孚医疗跌6.47%,收盘报52.8元,换手率2.27%,成交量4.4万手,成交额2.36亿元。重仓可孚医疗的前十大公募基金请见下表:该股最近90天内共有4家机构给出评级,买入评级4家。根据2025基金年报公募基金重仓股数据,重仓该股的公募基金共15家,其中持有数量最多的公募基金为国泰基金的国泰金鹰增长混合。该公募基金现任基金经理为王兆祥。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041300020132.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301087","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626108696","title":"AI医疗全场景落地,深睿医疗、飞利浦、可孚医疗亮相CMEF","url":"https://stock-news.laohu8.com/highlight/detail?id=2626108696","media":"微博财经-财道工作室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626108696?lang=zh_cn&edition=full","pubTime":"2026-04-12 22:15","pubTimestamp":1776003300,"startTime":"0","endTime":"0","summary":"深睿医疗、飞利浦、可孚医疗三家行业代表企业分别携AI原生全场景解决方案、平台化创新生态及智能化家用医疗器械新品重磅亮相,展现中国医疗AI从单点工具向全流程系统赋能的跨越式发展。本届展会,飞利浦本土创新成果尤为亮眼。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/wbstock/2026-04-12/doc-inhuhfpy5352936.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["PHG","159891","AGIX","BK4585","CHAT","ARTY","BK4588","AIPO","BK4082","301087","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626147021","title":"可孚医疗通过上市聆讯:年营收34亿利润3.7亿 张敏夫妇控制54%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2626147021","media":"雷递网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626147021?lang=zh_cn&edition=full","pubTime":"2026-04-11 14:08","pubTimestamp":1775887697,"startTime":"0","endTime":"0","summary":"可孚医疗科技股份有限公司(简称:“可孚医疗”)日前通过上市聆讯,准备在港交所上市。","market":"sh","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260411/6391151329304945897934975.PNG","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260411/6391151329304945897934975.PNG"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.leinews.com/n33257/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["IPOS","301087"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626607201","title":"夫妻店的资本局:可孚医疗冲刺港交所后得过三关","url":"https://stock-news.laohu8.com/highlight/detail?id=2626607201","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626607201?lang=zh_cn&edition=full","pubTime":"2026-04-10 16:23","pubTimestamp":1775809431,"startTime":"0","endTime":"0","summary":"文|《投资者网》蔡俊近期,可孚医疗公告港股IPO进展。根据公告,香港联交所上市委员审议公司上市申请。公司的联席保荐人收到香港联交所向其发出的信函,但该文件不构成正式的上市批准。2025年,可孚医疗一直在向市场表达全球化叙事,最终走向港交所。换言之,公司继续走并购的路径,向市场证明从 “国内渠道商” 蜕变为 “全球化消费医疗企业”,进而冲刺港交所上市。截至2025年,公司商誉3.7亿元,计提减值准备14.8万元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1775657163077112155","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK0251","301087"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624663847","title":"可孚医疗(301087)披露2025年年度分红派息实施公告,4月3日股价下跌0.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624663847","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624663847?lang=zh_cn&edition=full","pubTime":"2026-04-03 22:22","pubTimestamp":1775226137,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘,可孚医疗报收于56.01元,较前一交易日下跌0.67%,最新总市值为117亿元。该股当日开盘56.46元,最高57.27元,最低55.38元,成交额达1.09亿元,换手率为1.0%。可孚医疗于2026年4月3日披露《2025年年度分红派息实施公告》。本次分红不送红股,不以资本公积金转增股本。股权登记日为2026年4月9日,除权除息日为2026年4月10日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040300043509.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301087","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621870254","title":"可孚医疗(301087)披露2025年度网上业绩说明会安排,3月23日股价下跌4.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2621870254","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621870254?lang=zh_cn&edition=full","pubTime":"2026-03-23 22:33","pubTimestamp":1774276399,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘,可孚医疗报收于53.19元,较前一交易日下跌4.13%,最新总市值为111.11亿元。该股当日开盘55.05元,最高55.86元,最低52.2元,成交额达1.94亿元,换手率为1.86%。可孚医疗于近日披露《关于举行2025年度网上业绩说明会的公告》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032300039953.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301087","BK0251"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1777928408415,"stockEarnings":[{"period":"1week","weight":-0.0099},{"period":"1month","weight":-0.0375},{"period":"3month","weight":0.027},{"period":"6month","weight":0.2382},{"period":"1year","weight":0.6982},{"period":"ytd","weight":0.2116}],"compareEarnings":[{"period":"1week","weight":0.0046},{"period":"1month","weight":0.0566},{"period":"3month","weight":-0.0014},{"period":"6month","weight":0.0398},{"period":"1year","weight":0.2541},{"period":"ytd","weight":0.0361}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"可孚医疗科技股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"16386人(较上一季度减少3.61%)","perCapita":"11838股","listingDate":"2021-10-25","address":"湖南省长沙市雨花区环保东路一段87号","registeredCapital":"20889万元","survey":" 可孚医疗科技股份有限公司的主营业务是医疗器械研发、生产、销售和服务。公司的主要产品是血糖尿酸监测系列、血压计、血氧仪、体温计、胎心仪、居家检测试纸、矫正/矫姿系列、助听器、轮椅、护理床、助行器、移位机、听力计、敷贴/敷料系列、健康防护系列、感染防控系列、成人护理系列、造口护理系列、呼吸机、制氧机、雾化器、便携制氧器、鼻腔护理、理疗仪、膏贴、拔罐、针灸针、按摩器、艾叶及制成品、刮痧板。","listedPrice":93.09},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"可孚医疗(301087)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供可孚医疗(301087)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"可孚医疗,301087,可孚医疗股票,可孚医疗股票老虎,可孚医疗股票老虎国际,可孚医疗行情,可孚医疗股票行情,可孚医疗股价,可孚医疗股市,可孚医疗股票价格,可孚医疗股票交易,可孚医疗股票购买,可孚医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"可孚医疗(301087)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供可孚医疗(301087)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}